You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

dual-drug maintenance

Showing 9976 - 10000 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malaria Trial in Worldwide (KAE609, Coartem)

Completed
Has Results
  • Malaria
  • Lambarene, Gabon
  • +8 more
Oct 7, 2021

Community-acquired Pneumonia, Bacterial Pneumonia Trial in Cincinnati (CMTX-101, Placebo)

Recruiting
  • Community-acquired Pneumonia
  • Bacterial Pneumonia
  • Cincinnati, Ohio
    Medpace Clinical Pharmacology Unit
Jan 20, 2023

Hand Foot Skin Reaction Trial in Chicago (Sildenafil)

Completed
  • Hand Foot Skin Reaction
  • Chicago, Illinois
  • +1 more
Oct 29, 2021

Pulmonary Vascular Disorder, Primary Pulmonary Hypertension, Systemic Sclerosis Trial in Dresden, Heidelberg (Riociguat Oral

Recruiting
  • Pulmonary Vascular Disorder
  • +3 more
  • Riociguat Oral Tablet
  • Placebo
  • Dresden, Germany
  • +1 more
Jan 26, 2023

Surgical Injury Trial in Wuhan (Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato], 0.9% saline)

Not yet recruiting
  • Surgical Injury
  • Esketamine Hydrochloride 28 Mg in 0.2 mL NASAL SOLUTION [Spravato]
  • 0.9% saline
  • Wuhan, Hubei, China
    Department of Critical Care Medicine, Union Hospital, Tongji Med
Jul 12, 2022

Healthy Participants Trial in Brussels (Midazolam, PF-07321332/ritonavir + Midazolam, Ritonavir + Midazolam)

Completed
  • Healthy Participants
  • Brussels, Bruxelles-capitale, Région DE, Belgium
    Brussels Clinical Research Unit
Jan 18, 2022

Relapsed/Refractory Diffuse Large B Cell Lymphoma Trial in Seoul (Glofitamab, Poseltinib, Lenalidomide)

Recruiting
  • Relapsed/Refractory Diffuse Large B Cell Lymphoma
  • Glofitamab, Poseltinib, Lenalidomide
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Nov 28, 2022

Narcolepsy Trial in United States (SEP363856, Placebo)

Completed
  • Narcolepsy
  • Orange, California
  • +5 more
Aug 16, 2021

Stroke, Acute, Neuroprotection Trial in Beijing (Normobaric Hyperoxia, Sham Normobaric Hyperoxia, Endovascular Thrombectomy)

Recruiting
  • Stroke, Acute
  • Neuroprotection
  • Normobaric Hyperoxia
  • +2 more
  • Beijing, Beijing, China
    Xuan Wu Hospital，Capital Medical University
Sep 2, 2022

Cerebrovascular Accident Trial (Videographic feedback, Classic reeducation)

Not yet recruiting
  • Cerebrovascular Accident
  • Videographic feedback
  • Classic reeducation
  • (no location specified)
Aug 23, 2021

Allergy;Food, Allergy to Shrimp, Allergy to Cashew Nut (Disorder) Trial in Mountain View (Cashew or Shrimp Oral Immunotherapy)

Active, not recruiting
  • Allergy;Food
  • +2 more
  • Cashew or Shrimp Oral Immunotherapy
  • Mountain View, California
    Sean N Parker Center For Allergy and Asthma Research
May 26, 2022

Administration Choices of Vedolizumab and Outcomes for

Recruiting
  • Inflammatory Bowel Diseases
  • +2 more
    • Osijek, Croatia
    • +7 more
    May 31, 2022

    COVID-19, Long-COVID Trial in Germany (symptom-focused rehabilitation, usual care)

    Recruiting
    • COVID-19
    • Long-COVID
    • symptom-focused rehabilitation
    • usual care
    • Augsburg, Germany
    • +7 more
    Jun 2, 2022

    Osteosarcoma Trial in Shanghai (metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic

    Recruiting
    • Osteosarcoma
    • metastasectomy and pre-operative immunotherapy (gemcitabine and penpulimab ) and stereotactic body radiotherapy
    • Shanghai, Shanghai, China
      Ruijin Hospital, Shanghai Jiao Tong University, School of Medici
    Nov 1, 2023

    Atopic Dermatitis Trial in Los Angeles, Doral (Rocatinlimab, Placebo)

    Recruiting
    • Atopic Dermatitis
    • Los Angeles, California
    • +1 more
    Jun 7, 2023

    A Study of Adalimumab in Acute Vogt-Koyanagi-Harada Disease

    Recruiting
    • Vogt-Koyanagi-Harada Disease
    • Adalimumab
    • Tianjin, Tianjin, China
      Tianjin Medical University Eye Hospital
    Oct 19, 2022

    CT Perfusion Parameters Predict Vascular Pattern in

    Recruiting
    • Hepatocellular Carcinoma
    • CT perfusion examination
    • Guangzhou, Guangdong, China
      Cancer Center Sun Yat-sen University
    Dec 28, 2021

    COVID-19 Trial (Recommended treatment schedule, Usual care)

    Not yet recruiting
    • COVID-19
    • Recommended treatment schedule
    • Usual care
    • (no location specified)
    Feb 22, 2022

    Tourette Syndrome Trial in Worldwide (TEV-50717, Placebo)

    Completed
    Has Results
    • Tourette Syndrome
    • Gainesville, Florida
    • +55 more
    Nov 5, 2021

    Systemic Lupus Erythematosus Trial in Changchun (IL-2)

    Completed
    • Systemic Lupus Erythematosus
    • Changchun, Changchun/Jilin, China
      Sirui Yang
    Aug 16, 2022

    Waldenstrom Macroglobulinemia Trial in Germany, Greece (Ibrutinib / Bortezomib / Rituximab)

    Active, not recruiting
    • Waldenstrom Macroglobulinemia
    • Ibrutinib / Bortezomib / Rituximab
    • Berlin, Germany
    • +14 more
    Mar 7, 2022

    Acute Myeloid Leukemia, Adult Trial in Germany (Midostaurin)

    Terminated
    • Acute Myeloid Leukemia, Adult
    • Chemnitz, Germany
    • +3 more
    Jan 20, 2022

    Low Back Pain, Chronic Low-back Pain, Chronic Pain Trial (High intensity training, Moderate intensity training)

    Recruiting
    • Low Back Pain
    • +2 more
    • High intensity training
    • Moderate intensity training
    • Diepenbeek, Limburg, Belgium
      Hasselt University
    Oct 5, 2022

    Bariatric Surgery Candidate, Male Hypogonadism, Muscle Loss Trial in Esbjerg (Testosterone Undecanoate)

    Recruiting
    • Bariatric Surgery Candidate
    • +2 more
    • Testosterone Undecanoate
    • Esbjerg, Denmark
      HospitalSWD
    Oct 24, 2022

    Severe Infection Trial in Shanghai

    Not yet recruiting
    • Severe Infection
      • Shanghai, Shanghai, China
        Children's Hospital of Fudan University
      Jun 13, 2022